Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study.
Hiroaki TakahashiYoko SaitoKanon SugawaraMasaki SatoTomohiko TairabuneHaruki UjiieJunichi AsakaKenzo KudoPublished in: Cancer chemotherapy and pharmacology (2023)
TEWL can serve as a marker for acneiform rashes induced by anti-EGFR antibody drugs during cancer treatment.